Navigation Links
Spirus Medical Announces Japanese Regulatory Approval to Market ENDO-EASE® Product Line
Date:9/8/2010

STOUGHTON, Mass., Sept. 8 /PRNewswire/ -- Spirus Medical announced today that it has obtained marketing approval from the Japanese Ministry of Health, Labor and Welfare for the company's proprietary ENDO-EASE line of endoscopy devices. The Endo-Ease Endoluminal Advancement System features novel "over-tubes" that use a spiral design utilizing simple rotation to facilitate enteroscopy, colonoscopy and ileoscopy.

According to Spirus Medical, the Endo-Ease line is well suited for the Japanese endoscopy marketplace, which emphasizes in-hospital treatment.  The Endo-Ease allows both visualization and, if needed, appropriate treatment of gastrointestinal disease. Competing new platforms, such as ingestible "pill cameras", provide only detection, and are administered on an outpatient basis. Endoscopic treatment, under those regimens, needs to be scheduled for a second, in-hospital procedure.

Century Medical, Inc. (CMI), one of Japan's largest independent medical device distributors, has over 150 sales representatives throughout the country to serve one of the largest endoscopic markets in the world. Spirus first announced the partnership in October, 2009. "The approval is an important success for Spirus Medical and CMI's regulatory affairs teams, and will now allow CMI's extensive sales & marketing network to introduce the ground-breaking devices into Japan. We anticipate that the clinical benefits of the Endo-Ease will prove to be highly appealing to health care providers and their patients throughout Japan," said Robert Ailinger, Spirus Medical's Chief Operations Officer.

"We are pleased to be partnering with Spirus Medical, and we look forward to expanding awareness and adoption of the company's innovative technologies," said Akira Hoshino, President  & CEO of CMI.

"We foresee a highly productive collaboration with CMI as we work to further extend the applications and value of the Endo-Ease platform technology," said Steven J. Tallarida, President and CEO of Spirus Medical. "With several applications already developed in gastroenterology, and additional ones planned for future markets, we look forward to working with CMI to provide benefits for both the endoscopist and their patients."

Spirus Medical, Inc.

Spirus Medical is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component. For more information on Spirus Medical, visit www.spirusmed.com.


'/>"/>
SOURCE Spirus Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... Rancho Mirage, California (PRWEB) , ... February 10, ... ... Care Dental are working together to expand dental health services to the developmentally ... have moved We Care Dental’s operations to a new facility at 71-949 Highway ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy ... to associations of medical professionals throughout the country. The Guard was specifically designed ... policies and procedures, employee training, regulatory updates, and compliance coaching. , In addition ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
Breaking Medicine News(10 mins):